Inhibitors of topoisomerase II: Structure-activity relationships and mechanism of action of podophyllin congeners-Reference-Cited by-同舟云学术

Inhibitors of topoisomerase II: Structure-activity relationships and mechanism of action of podophyllin congeners

Published:1988-01 Issue: Volume:27 Page:211-214
ISSN:0065-2571
Container-title:Advances in Enzyme Regulation
language:en
Short-container-title:Advances in Enzyme Regulation

Author:

Long Byron H.,Stringfellow Dale A.

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology,Molecular Medicine

Reference90 articles.

1. Evidence that m-AMSA induces topoisomerase action;Marshall;FEBS Lett.,1983

2. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II;Tewey;Science,1984

3. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4′-(9-acridinylamino)-methanesulfon-m-anisidide;Nelson,1984

4. Intercative antitumor drugs interfere with the breakage-reunion of mammalian DNA topoisomerase II;Tewey;J. Biol. Chem.,1984

5. Inhibition of topoisomerase II by VP16-213 (Etoposide), VM26 (Teniposide), and structural congeners as an explanation for in vivo DNA breakage and cytotoxicity;Long,1983

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physicochemical investigations of interaction of antitumor etoposide with ionic and nonionic micelles: a spectroscopic, conductivity and voltammetric study;Journal of Dispersion Science and Technology;2023-12-22

2. Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA Fragility;Genes;2019-10-12

3. Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies;Pharmacology & Therapeutics;2019-09

4. Podophyllotoxin in Dermatology;Journal of the Dermatology Nurses' Association;2018-01

5. Involvement of RPL11 in the enhancement of P53 stability by a podophyllum derivative, a topoisomerase II inhibitor;Cell Biology International;2017-10-25